Novavax COVID vaccine
Scope
Date
~
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Airlines
Korean LCCs’ international flight recovery remains slow
South Korean budget airlines are seeing a slow recovery in international flights as key routes such as China and Japan have yet to normalize while t...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Batteries
LG Energy surrenders No. 2 EV battery position to BYD
LG Energy Solution Ltd., South Korea’s leading battery maker, gave up its second-largest position in the global electric vehicle cell market...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
ASK 2022
Korean real estate investors look to secure liquidity post-pandemic
South Korean real estate investors prefer liquidity and stable payback on investment, as well as investing in debts amid market uncertainty. The lim...
May 25, 2022 (Gmt+09:00)
-
Travel & Leisure
Lotte Hotel Yangon: Pain for POSCO International, Hotel Lotte
South Korea’s POSCO International Corp. and Hotel Lotte Co. have been suffering from sluggish earnings of their five-star hotel in Yangon, Mya...
May 23, 2022 (Gmt+09:00)
-
Real estate
Korea's top real estate managers bulk up assets in COVID-19
Real estate funds in South Korea have increased by 27% to 130 trillion won ($101.4 billion) from 102 trillion won over the past two years, accordi...
May 13, 2022 (Gmt+09:00)
-
Earnings
Korea’s major airlines continue to enjoy cargo boom
Korean Air Lines Co., the country’s top carrier, reported a record quarterly operating profit on the strong cargo business while its smaller d...
May 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
COVID test kit maker SD Biosensor buys Italian medical device firm
SD Biosensor Inc., South Korea’s top manufacturer of COVID-19 test kits, said on Friday that it has signed a deal to purchase a 100% stake i...
Apr 22, 2022 (Gmt+09:00)
-
Automobiles
SUV, minivan sales reach 52% of car market in Q1
Sales of leisure vehicles in South Korea, primarily sport utility vehicles (SUVs) and minivans, exceeded half of domestic finished car sales in the ...
Apr 18, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Private equity
MBK sees most productive year ever, returning $5.3 bn to investors
MBK Partners will be bold in moving into more Asian markets this year, wrote the company's founder and chairman Michael ByungJu Kim, in his annual l...
Mar 30, 2022 (Gmt+09:00)
-
Private equity
MBK sees most productive year ever, returning $5.3 bn to investors
MBK Partners will be bold in moving into more Asian markets this year, wrote the company's founder and chairman Michael ByungJu Kim, in his annual l...
Mar 27, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Airlines
Global airlines raise flights to pre-COVID levels on border reopening
Global airlines are increasing flights to pre-pandemic levels as countries worldwide are opening up their borders to support the tourism sector, ram...
Mar 14, 2022 (Gmt+09:00)
language -
Korean stock market
Korea reopening stocks rally as govt. eases COVID-19 restrictions
South Korea’s reopening stocks jumped on Friday as the government eases COVID-19-curbing restrictions and as the number of the Omicron variant...
Mar 11, 2022 (Gmt+09:00)
-
Electronics
Samsung Smart Monitor M8 available in S.Korea
The new Samsung Smart Monitor M8 is now available for sale in South Korea, Samsung Electronics Co. announced on Sunday.The product can stream serv...
Mar 06, 2022 (Gmt+09:00)
-
Entertainment
K-pop shares rebound on return to offline concerts
Shares of major South Korean entertainment companies are on an upward trend this month. The rebound is thanks to eased COVID-19 restrictions leading...
Feb 24, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
Pharmaceuticals
Celltrion, Humasis to ship $300 mn COVID-19 test kits to US
South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...
Feb 04, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung cuts NAND output in Xian on COVID-19 lockdown
Samsung Electronics Co., the world’s largest NAND flash memory chipmaker, said on Wednesday it is adjusting operations at its manufacturing fa...
Dec 29, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Economy
Korea lawmakers approve record $515 bn budget for 2022
South Korea’s parliament on Dec. 3 approved a record $515 billion spending for 2022 to support a recovery in Asia’s fourth-largest econo...
Dec 03, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to export COVID-19 treatment to Europe in 2021
South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...
Nov 30, 2021 (Gmt+09:00)
language -
Supply chain
Korea Inc. braces for rising costs, supply chain risks, volatile FX
Hopes for improving corporate earnings are rising as countries around the world are relaxing their anti-COVID-19 measures, but South Korean companie...
Nov 22, 2021 (Gmt+09:00)
-
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs